NicolasBrice

Partner

巴黎 + 33.1.56.59.39.09

聯絡

*Share

Nicolas Brice, who is an experienced lawyer and litigator in France, focuses on public law, government contracts, project and infrastructure contracts, regulatory law, and administrative litigation under French and European laws.

Nicolas has extensive experience in the proceedings and execution of procurement contracts and project financing, particularly concession contracts and public-private partnerships (PPPs) related to public utilities and infrastructure. He advises clients in all infrastructure and utilities sectors such as roads, railways, airports, ports, energy and renewable energy, smart grids, e-mobility, telecommunications, transportation, stadiums, museums, and universities. He has broad experience in relationships and negotiations with public bodies and advises clients that include private companies, banks, and administrative and regulatory agencies.

Nicolas handles French and European foreign investments authorization (foreign direct investment [FDI]) in all transactional activities: M&A, capital and financial markets, and real estate. He also handles sector specific regulation primarily in the areas of energy and renewable energy, telecommunications, and transportation.

Nicolas represents clients before administrative courts, both in contractual and extra-contractual litigation, involving the responsibility of administrative agencies.

執業經驗

  • Tender offer for Eurobio Scientific launched by NextStage AM and IK PartnersJones Day is advising Eurobio Scientific SA in the tender offer launched by a consortium led by the management of Eurobio Scientific and funds managed by NextStage AM and IK Investment Partners, at a price of €25.3 per share increased by €1.25 per share if the threshold of 90% of Eurobio Scientific's capital and voting rights is reached, representing a maximum amount of approximately €161 million and valuating Eurobio Scientific at approximately €270 million.
  • Amolyt Pharma acquired by AstraZenecaJones Day advised Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, in its $1.05 billion acquisition by AstraZeneca.
  • Silver Lake Waterman, Eurazeo, Partech Partners, Eight Roads, F-Prime, and Serena Capital participate in $54 million Series C financing of OdasevaJones Day advised Silver Lake Waterman, the lead new investor, and Eurazeo, a new investor, as well as historical investors Partech Partners, Eight Roads, F-Prime and Serena Capital in connection with the $54 million Series C financing of Odaseva, the leading enterprise data security platform for Salesforce, along with new investor Crescent Cove.
  • Société Générale sells Société Générale Equipment Finance's (SGEF) activitiesJones Day is advising Société Générale in the sale of the professional equipment financing businesses operated by Societe Generale Equipment Finance (SGEF) to Groupe BPCE.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • Sanofi sells portfolio of well-established consumer healthcare brands to STADAJones Day advised Sanofi in the sale of a portfolio of 7 well-established consumer healthcare brands across several countries, including Belgium, Germany, Hungary, Spain, the U.K., as well as Nordic countries, to STADA Arzneimittel AG.
  • Arverne Group combines with Transition to publicly list on Euronext Paris the future French leader in geothermal and low-carbon lithium to drive energy transitionJones Day advised Arverne Group SAS, a French company ("Arverne"), in its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • TotalEnergies fully acquires Total Eren after a successful strategic alliance of five yearsJones Day acted as Antitrust counsel to TotalEnergies in its buyout of Total Eren's other shareholders, increasing its stake from close to 30% to 100% after a successful strategic alliance of five years.
  • Orano and XTC New Energy create two JVs dedicated to the production of batteries for electric vehiclesJones Day is advising Orano in the context of the setting-up of two joint-ventures dedicated to the production of critical materials for batteries for electric vehicles, together with Chinese group XTC New Energy.
  • True Green Capital Management invests in Faradae SASJones Day advised True Green Capital Management LLC in the acquisition of a controlling interest in Faradae SAS, an independent renewable power producer based in Lyon, France, that targets French real estate investment trusts ("REITs") and other corporate customers for solar installations.
  • TotalEnergies' affiliate Cray Valley sells three product lines to Pacific Avenue Capital PartnersJones Day is advising Total Energies on its sale of three product lines to Pacific Avenue Capital Partners (Wingtack®, PolyBD® and Dymalink®) developed by Cray Valley, its resin production and sales affiliate.
  • Real Alloy sells European business to SpeiraJones Day advised Real Alloy Holding, LLC in the sale of its European aluminum and magnesium recycling operations to Speira GmbH, an affiliate of KPS Capital Partners.
  • CVE raises €100 million from ICG InfraJones Day advised CVE, a France-based independent producer of renewable energy across multiple countries and sources of power, in connection with its €100 million financing round led by Intermediate Capital Group plc, a global alternative asset manager, through its infrastructure investment arm (ICG Infra).
  • Uniphore Technologies acquires HexagonJones Day advised Uniphore Technologies, a provider of conversational artificial intelligence and automation, in the acquisition of Hexagone, which fuses voice, visual, and text-based data to provide AI-derived insights to help better understand human behavior.
  • Sanofi sells customer healthcare products to ZentivaJones Day advised Sanofi in the sale of a portfolio of 12 customer healthcare products marketed in Europe to Zentiva K.S, a multinational pharmaceutical company headquartered in Prague, Czech Republic.
  • Électricité de Strasbourg forms JV with ErametJones Day advised Électricité de Strasbourg, an energy provider in Alsace (France), in the formation of a joint venture with Eramet, one of the leading French actors in the mining and metallurgy industries, to develop and use joint capabilities for the extraction, refining and production of lithium from geothermal resources, with a targeted annual volume of 10,000 tons of lithium corresponding to the volume necessary to produce c.250,000 batteries for electric vehicles per year).
  • Swile and Groupe BPCE to combine to create global leader in employee benefitsJones Day advised Swile, a worktech unicorn, in the acquisition of Bimpli, a subsidiary of Groupe BPCE and leader in employee services and benefits in France.
  • Ansys acquires automotive simulation channel partner DYNAmoreJones Day is representing Ansys, Inc. in the acquisition of the DYNAmore business (“DYNAmore”), a Stuttgart, Germany-headquartered company who has historically distributed Ansys’ LS-DYNA crash test simulation software to virtually all major European car manufacturers.
  • Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholdersJones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.
  • Albaugh acquires RotamJones Day advised Albaugh, LLC in the $197.5 acquisition of Rotam Global AgroSciences Limited, a company headquartered in Hong Kong and publicly listed on the Taiwan Stock Exchange.
    •

    February 2024 Commentary

    European Commission Unveils Plan Aimed at Strengthening Economic Security

    November 2023 Commentary

    Ireland Introduces Foreign Investment Screening Regime

    October 2023 Alert

    European Commission Signals Increased Scrutiny in Semiconductors, AI, Quantum Technologies, and Biotechnologies

    August 2023 Commentary

    Luxembourg Adopts New Foreign Direct Investment Screening Regime

    July 2023 Commentary

    ECJ Clarifies Conditions Under Which Member States Can Block Foreign Direct Investments

    JULY 2023 Commentary

    Foreign Direct Investment Screening in the Netherlands: New Regime In Force

    July 2023 Commentary

    Belgian Foreign Investment Screening Law Takes Effect

    January 2023 White Paper

    Key Lessons from UK National Security and Investment Regime's First Year

    December 2022 Alert

    EU Proposes Corporate Criminal Penalties for Sanctions Breaches

    October 2022 Alert

    The French Ministry of Economy Releases Guidelines on Foreign Direct Investments
    顯示全部

    March 11-13, 2024 Speaking Engagements

    Jones Day lawyers to attend IJ LATAM 2024

    • 1er octobre 2015
      Les marchés de partenariat : les principales différences avec le contrat de partenariat
    • 21 mai 2014
      Les nouvelles directives Marchés publics et Concessions

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.